Crescita Therapeutics Inc. (TSX: CTX)
Canada
· Delayed Price · Currency is CAD 0.640
+0.010 (1.59%)
Aug 22, 2024, 1:48 PM EDT
Crescita Therapeutics Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Year Ending | TTM | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | Dec 31, 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
| Net Income | -2.98 | -1.99 | 0.86 | -1.11 | 0.04 | 1.86 | Upgrade
|
| Depreciation & Amortization | 1.45 | 1.51 | 1.47 | 1.38 | 1.49 | 1.73 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | - | - | - | 1.92 | - | Upgrade
|
| Loss (Gain) on Equity Investments | 0.01 | -0.02 | 0.06 | -0.01 | - | - | Upgrade
|
| Stock-Based Compensation | 0.07 | 0.08 | 0.22 | 0.27 | 0.16 | 0.29 | Upgrade
|
| Other Operating Activities | 0.38 | 0.88 | 0.08 | 0.61 | 0.43 | -0.29 | Upgrade
|
| Change in Accounts Receivable | 1.76 | 3.54 | -2.44 | -2.1 | 1.43 | 2.81 | Upgrade
|
| Change in Inventory | -0 | -0.92 | -1.78 | -1.38 | -0.04 | -1.34 | Upgrade
|
| Change in Accounts Payable | 0.29 | -1.29 | 0.23 | 0.99 | 0.33 | 0.16 | Upgrade
|
| Change in Other Net Operating Assets | -0.18 | 0.27 | 0.27 | -0.27 | -0.14 | 0.09 | Upgrade
|
| Operating Cash Flow | 0.79 | 2.08 | -1.02 | -1.6 | 5.61 | 5.31 | Upgrade
|
| Operating Cash Flow Growth | 74.17% | - | - | - | 5.69% | - | Upgrade
|
| Capital Expenditures | -1.05 | -0.13 | -0.23 | -0.35 | -0.06 | -0.22 | Upgrade
|
| Investment in Securities | - | - | -0.06 | - | - | - | Upgrade
|
| Other Investing Activities | - | - | - | -0.5 | - | - | Upgrade
|
| Investing Cash Flow | -1.05 | -0.13 | -0.29 | -0.85 | -0.06 | -0.22 | Upgrade
|
| Long-Term Debt Repaid | - | -0.41 | -1.37 | -0.35 | -0.36 | -3.89 | Upgrade
|
| Total Debt Repaid | -0.43 | - | - | - | - | - | Upgrade
|
| Net Debt Issued (Repaid) | -0.43 | -0.41 | -1.37 | -0.35 | -0.36 | -3.89 | Upgrade
|
| Issuance of Common Stock | 0.02 | 0.02 | 0.01 | - | - | - | Upgrade
|
| Repurchase of Common Stock | -0.52 | -0.39 | -0.43 | -0.1 | -0.07 | -0.26 | Upgrade
|
| Other Financing Activities | -0.05 | - | -0.05 | -0.05 | -0.05 | -0.25 | Upgrade
|
| Financing Cash Flow | -0.98 | -0.78 | -1.85 | -0.5 | -0.48 | -4.39 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | -0.01 | 0.06 | -0.01 | -0.06 | -0.02 | Upgrade
|
| Net Cash Flow | -1.21 | 1.15 | -3.09 | -2.95 | 5.01 | 0.68 | Upgrade
|
| Free Cash Flow | -0.26 | 1.94 | -1.25 | -1.94 | 5.55 | 5.09 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 9.00% | - | Upgrade
|
| Free Cash Flow Margin | -1.52% | 11.09% | -5.31% | -11.59% | 35.48% | 22.79% | Upgrade
|
| Free Cash Flow Per Share | -0.01 | 0.10 | -0.06 | -0.09 | 0.26 | 0.23 | Upgrade
|
| Cash Interest Paid | 0.05 | 0.06 | 0.11 | 0.16 | 0.15 | 0.51 | Upgrade
|
| Levered Free Cash Flow | -0.04 | 2.06 | -1.56 | -2.29 | 3.77 | 5.84 | Upgrade
|
| Unlevered Free Cash Flow | 0.01 | 2.11 | -1.46 | -2.14 | 3.92 | 6.26 | Upgrade
|
| Change in Net Working Capital | -1.58 | -1.88 | 3.25 | 2.51 | -1.82 | -1.36 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.